高度肝损伤患者的REBOA可能与较差的预后相关。

IF 2.7 3区医学 Q1 SURGERY American journal of surgery Pub Date : 2024-12-31 DOI:10.1016/j.amjsurg.2024.116174

Wei Huang, Naveen Balan, Feifei Jin, Yu Cheng Chiu, Demetrios Demetriades

{"title":"高度肝损伤患者的REBOA可能与较差的预后相关。","authors":"Wei Huang, Naveen Balan, Feifei Jin, Yu Cheng Chiu, Demetrios Demetriades","doi":"10.1016/j.amjsurg.2024.116174","DOIUrl":null,"url":null,"abstract":"Background: Although controversial, resuscitative endovascular balloon occlusion of the aorta (REBOA) has been used to manage liver injuries. This matched cohort study evaluated outcomes in severe liver injuries treated with REBOA or without REBOA.Methods: Trauma Quality Improvement Program database study. Patients with high-grade liver injuries (IV and V) treated with REBOA were propensity score matched (1:2) with similar patients managed without REBOA. Outcomes included mortality and complications.Results: 252 patients treated with REBOA were matched with 503 patients managed without REBOA. Overall mortality was significantly higher in the REBOA group [57.9 % vs. 35.2 % (p < 0.001)]. The REBOA group patients had higher blood product transfusion requirements.Conclusion: REBOA use in patients with high-grade liver injuries may be associated with poorer outcomes.","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":"241 ","pages":"116174"},"PeriodicalIF":2.7000,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"REBOA in patients with high-grade liver injury may be associated with worse outcomes.\",\"authors\":\"Wei Huang, Naveen Balan, Feifei Jin, Yu Cheng Chiu, Demetrios Demetriades\",\"doi\":\"10.1016/j.amjsurg.2024.116174\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Although controversial, resuscitative endovascular balloon occlusion of the aorta (REBOA) has been used to manage liver injuries. This matched cohort study evaluated outcomes in severe liver injuries treated with REBOA or without REBOA.Methods: Trauma Quality Improvement Program database study. Patients with high-grade liver injuries (IV and V) treated with REBOA were propensity score matched (1:2) with similar patients managed without REBOA. Outcomes included mortality and complications.Results: 252 patients treated with REBOA were matched with 503 patients managed without REBOA. Overall mortality was significantly higher in the REBOA group [57.9 % vs. 35.2 % (p < 0.001)]. The REBOA group patients had higher blood product transfusion requirements.Conclusion: REBOA use in patients with high-grade liver injuries may be associated with poorer outcomes.\",\"PeriodicalId\":7771,\"journal\":{\"name\":\"American journal of surgery\",\"volume\":\"241 \",\"pages\":\"116174\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.amjsurg.2024.116174\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amjsurg.2024.116174","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

摘要

背景：尽管存在争议，复苏血管内球囊阻断主动脉（REBOA）已被用于治疗肝损伤。这项匹配的队列研究评估了用REBOA或不使用REBOA治疗严重肝损伤的结果。方法：创伤质量改善计划数据库研究。接受REBOA治疗的高级别肝损伤（IV和V级）患者与未接受REBOA治疗的类似患者的倾向评分匹配（1:2）。结果包括死亡率和并发症。结果：252例接受REBOA治疗的患者与503例未接受REBOA治疗的患者相匹配。REBOA组的总死亡率显著高于REBOA组[57.9% vs. 35.2%] (p)结论：高度肝损伤患者使用REBOA可能与较差的预后相关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

REBOA in patients with high-grade liver injury may be associated with worse outcomes.

Background: Although controversial, resuscitative endovascular balloon occlusion of the aorta (REBOA) has been used to manage liver injuries. This matched cohort study evaluated outcomes in severe liver injuries treated with REBOA or without REBOA.

Methods: Trauma Quality Improvement Program database study. Patients with high-grade liver injuries (IV and V) treated with REBOA were propensity score matched (1:2) with similar patients managed without REBOA. Outcomes included mortality and complications.

Results: 252 patients treated with REBOA were matched with 503 patients managed without REBOA. Overall mortality was significantly higher in the REBOA group [57.9 % vs. 35.2 % (p < 0.001)]. The REBOA group patients had higher blood product transfusion requirements.

Conclusion: REBOA use in patients with high-grade liver injuries may be associated with poorer outcomes.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

American journal of surgery 医学-外科

CiteScore

5.00

自引率

6.70%

发文量

570

审稿时长

56 days

期刊介绍： The American Journal of Surgery® is a peer-reviewed journal designed for the general surgeon who performs abdominal, cancer, vascular, head and neck, breast, colorectal, and other forms of surgery. AJS is the official journal of 7 major surgical societies* and publishes their official papers as well as independently submitted clinical studies, editorials, reviews, brief reports, correspondence and book reviews.